Top Markets
#1 Geodnet Geodnet +29.44%
#2 XPIN Network XPIN Network +28.39%
#3 Ore Ore +23.60%
#4 EXOD EXOD +22.08%
#5 AUKI AUKI +21.42%
#6 The Black Bull The Black Bull +21.41%
#7 Verus Coin Verus Coin +20.47%
#8 Arowana Arowana +20.04%
#9 SSV Network SSV Network +17.92%
#10 Ethena Staked ENA Ethena Staked ENA +16.65%
Coin of the day
Geodnet Geodnet
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
Pozycja w akcjach #25185
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
Cena akcji
$1.95
Ostatnia synchronizacja: 2022-07-29
Kapitalizacja rynkowa
$52.48M
Zmiana (1 dzień)
2.63%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Cortexyme, Inc. (CRTX)

Kategoria

Healthcare
Historia ceny akcji dla Cortexyme, Inc. (CRTX)
Najwyższa cena zamknięcia: $2.18 dnia 2022-07-01

Najniższa cena zamknięcia: $26.37 dnia 2019-05-01
Historia cen akcji firmy Cortexyme, Inc. od 2019 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $539.14 35.65%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.21%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -18.24%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $760.57 8.46%
CH
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $130.43 397.46%
US